Global Medical Lasers System Market Analysis, Share, Trends and Forecast by 2024

The global clinical chemistry analyzers market is expected to reach USD 16.0 billion by 2025, according to a new study by Grand View Research, Inc. The growing prevalence of chronic diseases is anticipated to be responsible for the high urgency to adopt clinical chemistry analyzers, which thereby widens the scope for growth during the forecast period. In addition, growing base of geriatric and bariatric population, which is highly susceptible to chronic diseases, is presumed to impel the demand further. Consequently, the resultant high sample volume requiring high capability analyzing devices is driving the market growth.

Browse the report: http://www.orbisresearch.com/reports/index/clinical-chemistry-analyzers-market-analysis-by-product-analyzers-reagents-by-test-bmp-electrolyte-panel-liver-panel-lipid-profile-renal-profile-thyroid-function-profile-specialty-chemical-tests-by-end-use-and-segment-forecasts-2014-2025

Moreover, increasing awareness pertaining to benefits associated with these devices is also a high impact rendering driver for clinical chemistry analyzers market. Advent of advanced chemistry analyzers has resulted in improved point-of-care testing capabilities, and thus created high potential growth opportunities for the market. In addition, technological advancements in preanalytical, analytical, and post analytical stages due to analyzing devices & reagents improved their diagnostic capabilities and overall efficiency, which is predicted to propel the growth further. These advancements include advent of microchips, sensors, chemometrics, and robotics. Furthermore, consistent efforts by public as well private healthcare organizations to increase the reliability of data have rapidly engendered the integration of automated chemistry analyzers and immunoassay systems, thereby resulting in overall reduction of workload in laboratories, thus propelling the demand.

Further Key Findings from the Study Suggest:
Reagents held a substantial share in product segment in 2015. The substantial share can be attributed to increasing reagent rental agreements and availability resulting in quick global access.

Lipid panel is anticipated to exhibit lucrative CAGR during the forecast period owing to increasing adoption, as the demand for screening tests for cholesterol and triglyceride levels in case of cardiovascular disorders and diabetes has increased.

In 2016, North America accounted for substantial share in the global clinical chemistry analyzers market, as a consequence of local presence of prominent companies involved in high R&D investments.

Request a sample of the report: http://www.orbisresearch.com/contacts/request-sample/230156

Asia Pacific is anticipated to grow at an exponential CAGR due to unmet patient needs, continuous technological & infrastructural upgradation, and growing healthcare expenditure.

Some key participants such as Mindray Medical International Ltd.; Johnson & Johnson; and F.Hoffmann-La Roche Ltd. are undertaking various sustainability strategies, such as new product development & frequent product approvals, to gain competitive advantage.

For instance, in August 2016, Mindray announced the premarket FDA clearance for Mindray BA-800M clinical chemistry analyzer allowing it to distribute its product.

Buy the report@http://www.orbisresearch.com/contact/purchase/230156

Major Points From Table Of Contents:

Chapter One: Research Methodology & Scope

Chapter Two: Executive Summary

Chapter Three: Clinical Chemistry Analyzers Market Variables, Trends & Scope

Chapter Four: Clinical Chemistry Analyzers Market: Product Estimates & Trend Analysis

Chapter Five: Clinical Chemistry Analyzers Market: Test Estimates & Trend Analysis

Chapter Six: Clinical Chemistry Analyzers Market: End-Use Estimates & Trend Analysis

Chapter Seven: Clinical Chemistry Analyzers Market: Regional Estimates & Trend Analysis, by Product, Test & End-Use

Chapter Eight: Competitive Landscape

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Information:

Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Email: sales@orbisresearch.com

This release was published on openPR.